People · Operator
Named in public records as an officer, director or promoter · active 2021–2021 · Other, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Churchill Parent Holdings, LLC | — | Other | Series B | $35.3M | $469.1M | 2021 |
| Reset Pharmaceuticals, Inc. | — | Pharmaceuticals | Series A | $11.1M | $183.5M | 2021 |
Philip Taub at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Philip Taub on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Matthew Perelman | 1 | 10 |
| Alex Sloane | 1 | 7 |
| KEITH MITCHELL | 1 | 4 |
| Scott Leffler | 1 | 2 |
| Jan-Anders Karlsson | 1 | 2 |
| Stuart Crum | 1 | 1 |
| John Andreadis | 1 | 1 |
| Tim Schlidt | 1 | 1 |
| Christopher Kozina | 1 | 1 |
| Vartan Jerian | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.